Annals of Oncology · 2015 · 35 citations · 11 references
MedicineOncologyPharmacologyMetastasisMolecular OncologyNeoplasiaCancer ImmunotherapyKidney CancerMalignant NeoplasmsMtor Inhibitor TherapyRenal Cell CarcinomaRenal NeoplasmsEverolimus TreatmentEverolimus-based RegimensMetastatic Kidney CancerMetastatic Renal Cell Carcinoma TherapyMtor InhibitionPi3k-akt-mtor SignalingRenal Cell Carcinoma BiomarkersRenal Malignancy
11
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Prognostic relevance of the mTOR pathway in renal cell carcinoma
Allan J. Pantuck, David B. Seligson, Tobias Klatte et al. · Cancer · 2007 · 348 citations
Medicine, Oncology, Pharmacology +17
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy1
Fu L. Luan, Minoru Hojo, Mary A. Maluccio et al. · Transplantation · 2002 · 235 citations
Medicine, Oncology, Pharmacology +15